International Dermatology Outcome Measures (IDEOM): Report From the 2022 Annual Meeting

Kathryn Lee, Michael J. Woodbury, Melissa Peri Zundell, Rosario Agüero, Jenna Yousif, Samuel Clay Williams, David Rosmarin, Nanette Silverberg, Diane Thiboutot, Cecilia Larocca, Michi M. Shinohara, Arash Mostaghimi, Sonja Ständer, Antonio Martorell, Tarannum Jaleel, Richard L. Torbeck, Daniel M. Siegel, Lourdes Perez-Chada, Vibeke Strand, April W. ArmstrongJoseph F. Merola, Alice B. Gottlieb

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The International Dermatology Outcome Measures (IDEOM) is a non-profit organization dedicated to the advancement of evidence-based, consensus-driven outcome measures in dermatological diseases. Researchers and stakeholders from various backgrounds collaborate to develop these objective benchmark metrics to further advance treatment and management of dermatologic conditions. Summary: The 2022 IDEOM Annual Meeting was held on June 17-18, 2022. Leaders and stakeholders from the hidradenitis suppurativa, acne, vitiligo, actinic keratosis, alopecia areata, itch, cutaneous lymphoma, and psoriatic disease workgroups discussed the progress of their respective outcome-measures research. This report summarizes each workgroup’s updates from 2022 and their next steps as established during the 2022 IDEOM Annual Meeting.

Original languageEnglish (US)
Pages (from-to)1153-1159
Number of pages7
JournalJournal of Drugs in Dermatology
Volume22
Issue number12
DOIs
StatePublished - Dec 2023

All Science Journal Classification (ASJC) codes

  • General Medicine

Cite this